Acadia Healthcare Company is part of the healthcare sector and is in the health care providers industry. The company CEO is Debra K. Osteen. Acadia Healthcare Co Inc operates mental healthcare facilities in the United States. It addresses behavioral abnormalities in psychiatric facilities, substance abuse facilities, and residential treatment centers.
Previous Intraday Trading Performance:
The ACHC stock showed a previous change of -0.30% with an open at 34.03 and a close of 33.81. It reached an intraday high of 34.45 and a low of 33.66.
The stock has a market cap of $3.0b with 88.4m shares outstanding, of which the float is 87.3m shares. Trading volume reached 869,992 shares compared to its average volume of 708,447 shares. Based on the current average volume and close price, the trading liquidity is bad, highly speculative and an investor may want to avoid this stock.
Historical Trading Performance:
Over the last five trading days, Acadia Healthcare Company shares returned 0.27% and in the past 30 trading days it returned 4.45%. Over three months, it changed 13.92%. In one year it has changed -16.87% and within that year its 52-week high was 45.35 and its 52-week low was 24.27. ACHC stock is 39.31% above its 52 Week Low.
Our calculations show a 200 day moving average of 32.55 and a 50 day moving average of 31.75. Currently ACHC stock is trading 3.87% above its 200 day moving average and may be a good opportunity to buy.
The last annual fiscal EPS for the company was reported at -2.01 that ended on 31st of December 2018. Based on 8 analyst estimates, the consensus EPS for the next quarter is 0.35. The TTM EPS is 2.24, which comes to a TTM PE of 15.09.
Below was the last reported quarterly diluted earnings per share:
|1st||Qtr of 2019||(Reported on 04/30/2019):||0.34|
|4th||Qtr of 2018||(Reported on 02/28/2019):||-3.80|
|3rd||Qtr of 2018||(Reported on 11/05/2018):||0.53|
|2nd||Qtr of 2018||(Reported on 07/30/2018):||0.67|
|1st||Qtr of 2018||(Reported on 05/01/2018):||0.58|
Base on our calculations, the intrinsic value per share is 23.31, which means it may be overvalued by -45.07%.
Indicators to Watch:
The current calculated beta is 0.64.
Based on last reported financials, the company’s return on equity is -8.10%, return on assets is -3.08%, profit margin is -6.47%, price-to-sales is 0.99 and price-to-book is 1.25.
All scores are out of six:
1 :Valuation Score
0 :Past Performance Score
1 :Financial Strength Score
3 :Future Growth Score
0 :Dividend Score
1 :Overall Score